{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:06:07Z","timestamp":1762887967961,"version":"3.45.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EClinicalMedicine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.eclinm.2020.100350","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T14:06:28Z","timestamp":1588255588000},"page":"100350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A descriptive study of racial inequalities in mortality from hepatocellular cancer before and after licensure of lifesaving drugs for hepatitis C virus in the United States"],"prefix":"10.1016","volume":"22","author":[{"given":"Robert S","family":"Levine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C","family":"Mejia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason L","family":"Salemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra J","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muktar H","family":"Aliyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baqar A","family":"Husaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger J","family":"Zoorob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles H","family":"Hennekens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2020.100350_bib0001","series-title":"Schottenfeld and fraumeni cancer epidemiology and prevention","first-page":"635","article-title":"Liver cancer. Chapter 33 in thun MJ, (Lead editor), linet MS, cerhan JR, haiman CD and schottenfeld D (Co-Editors) and landgren am (Project manager)","author":"London","year":"2018"},{"issue":"1","key":"10.1016\/j.eclinm.2020.100350_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.soc.2014.09.001","article-title":"Epidemiology of hepatocellular carcinoma","volume":"24","author":"Lafaro","year":"2015","journal-title":"Surg Oncol Clin N Am"},{"issue":"9","key":"10.1016\/j.eclinm.2020.100350_bib0003","first-page":"1312","article-title":"Annual report to the nation on the status of cancer, 1975\u20132012","volume":"122","author":"Ryerson","year":"2016","journal-title":"Featur Increas Incidence Liver Cancer"},{"issue":"4","key":"10.1016\/j.eclinm.2020.100350_bib0004","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/ajg.2014.11","article-title":"Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States","volume":"109","author":"Altekruse","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.eclinm.2020.100350_bib0005","unstructured":"Hepatitis Central. Medications to treat hepatitis c \u2013 a timeline. Available at URL: https:\/\/www.hepatitiscentral.com\/medications-to-treat-hepatitis-c-a-timeline\/Accessed May 26, 2019 and March 22, 2020."},{"key":"10.1016\/j.eclinm.2020.100350_bib0006","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12962-015-0046-8","article-title":"Cost-effectiveness analysis of oral anti-viral drugs used for treatment of chronic hepatitis B in Turkey","volume":"13","author":"Kockaya","year":"2015","journal-title":"Cost Eff Resour Alloc"},{"issue":"4","key":"10.1016\/j.eclinm.2020.100350_bib0007","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1353\/dem.2004.0030","article-title":"The increasing racial disparity in infant mortality: respiratory distress syndrome and other causes","volume":"41","author":"Frisbie","year":"2004","journal-title":"Demography"},{"issue":"6","key":"10.1016\/j.eclinm.2020.100350_bib0008","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2105\/AJPH.2009.170241","article-title":"Examination of inequalities in HIV\/AIDS mortality in the united states from a fundamental cause perspective","volume":"100","author":"Rubin","year":"2010","journal-title":"Am J Public Health"},{"issue":"11","key":"10.1016\/j.eclinm.2020.100350_bib0009","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.2105\/AJPH.2009.170795","article-title":"Increased black:white disparities in mortality following lifesaving innovations: a possible consequence of us federal laws","volume":"100","author":"Levine","year":"2010","journal-title":"Am J Public Health"},{"key":"10.1016\/j.eclinm.2020.100350_bib0010","unstructured":"Centers for Disease Control and Prevention, National center for health statistics. Compressed Mortality File 1979-1998. CDC WONDER On-line Database, compiled from Compressed Mortality File CMF 196801988, Series 20, No. 2A, 2000 and CMF 1989-1998, Series 20, No. 2E, 2004. Accessed at http:\/\/wonder.cdc.gov\/cmf-icd9. html April 2019-March2020."},{"key":"10.1016\/j.eclinm.2020.100350_bib0011","unstructured":"Centers for Disease Control and Prevention, National center for health statistics. Compressed Mortality File 1999-2016 on CDC WONDER Online Database, released June 2017. Data are from the Compressed Mortality File 1999\u20132016 Series 20 No. 2U, 2016, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. Accessed at http:\/\/wonder.cdc.gov\/cmf-idc10.html April 2019-March2020."},{"key":"10.1016\/j.eclinm.2020.100350_bib0012","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.eclinm.2020.100350_bib0013","unstructured":"Joinpoint Regression Program, Version 4.6.0.0 - April 2018; Statistical methodology and applications branch, Surveillance Research Program, National Cancer Institute."},{"key":"10.1016\/j.eclinm.2020.100350_bib0014","unstructured":"Anon. Percentage change calculator. Available at URL: http:\/\/www.percentage-change-calculator.com\/calculate.php. Accessed June14, 2019."},{"issue":"4","key":"10.1016\/j.eclinm.2020.100350_bib0015","first-page":"147","article-title":"treatment \u2013 yesterday, tomorrow and \u2026","volume":"40","author":"Weitzel","year":"2017","journal-title":"Med Monatsschr Pharm"},{"issue":"1","key":"10.1016\/j.eclinm.2020.100350_bib0016","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/qje\/qjx029","article-title":"Tuskegee and the health of black men","volume":"133","author":"Alsan","year":"2018","journal-title":"Q J Econ"},{"issue":"1","key":"10.1016\/j.eclinm.2020.100350_bib0017","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10461-012-0323-x","article-title":"The impact of african americans\u2019 beliefs about hiv medical care on treatment adherence: a systematic review and recommendations for interventions","volume":"17","author":"Gaston","year":"2013","journal-title":"AIDS Behav"},{"key":"10.1016\/j.eclinm.2020.100350_bib0018","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/hep.28901","article-title":"The association between race\/ethnicity and the effectiveness of direct antiviral agents for hepatitis C virus infection","volume":"65","author":"Su","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.eclinm.2020.100350_bib0019","doi-asserted-by":"crossref","first-page":"e00379","DOI":"10.1002\/prp2.379","article-title":"Race affects SVR12 in a large and ethnically diverse hepatitis C-infected patient population following treatment with direct-acting antivirals: analysis of a single-center department of veterans affairs cohort","volume":"6","author":"Benhammou","year":"2018","journal-title":"Pharmacol Res Perspect"},{"issue":"4","key":"10.1016\/j.eclinm.2020.100350_bib0020","first-page":"168","article-title":"Using cancer registries to assess the accuracy of primary liver or intrahepatic bile duct cancer as the underlying cause of death, 1999-2010","volume":"40","author":"Polednak","year":"2013","journal-title":"J Registry Manag"},{"key":"10.1016\/j.eclinm.2020.100350_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2019.05.008","article-title":"Liver cancer: a leading cause of cancer death in the united states and the role of the 1945-1965 birth cohort by ethnicity","author":"Pinheiro","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.eclinm.2020.100350_bib0022","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/009885880903500203","article-title":"The global health licensing program: a new model for humanitarian licensing at the university level","volume":"35","author":"Roose-Snyder","year":"2009","journal-title":"Am J Law Med Ethics"}],"container-title":["EClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537020300948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537020300948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:01:05Z","timestamp":1762887665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537020300948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":22,"alternative-id":["S2589537020300948"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2020.100350","relation":{},"ISSN":["2589-5370"],"issn-type":[{"type":"print","value":"2589-5370"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A descriptive study of racial inequalities in mortality from hepatocellular cancer before and after licensure of lifesaving drugs for hepatitis C virus in the United States","name":"articletitle","label":"Article Title"},{"value":"EClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2020.100350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100350"}}